Modified/Controlled Release of Solid Oral Drugs
Flamel’s Micropump® platform permits either extended, or both delayed and extended, delivery of small molecule drugs via the oral route.
Micropump consists of a multiple-particulate system containing 5,000 to 10,000 microparticles per capsule or tablet. The 200-500 microns diameter-sized microparticles are released in the stomach and pass into the small intestine, where each microparticle, operating as a miniature delivery system, releases the drug at an adjustable rate and over an extended period of time.
The Micropump® platform has successfully transitioned to commercial stage with Coreg CR®.